van der Lee J Hanneke, Offringa Martin
Universiteit van Amsterdam, Academisch Medisch Centrum, Emma Kinderziekenhuis, Amsterdam, The Netherlands.
Ned Tijdschr Geneeskd. 2009;153:A1310.
Accumulating evidence shows that children are not simply little adults, and adapting adult evidence on medical care to children can result in ineffective or even unsafe medical care. The growing number of trials in children reflects this imperative to create a child-specific evidence base. Motivated by the increased focus on clinical research in children and the stark deficiencies in knowledge about the best ways to deal with methodological and practical challenges of research in children, the STaR Child Health initiative was created. It aims to enhance the design, conduct, and reporting of trials in children. The initiative brings together an international group of leading methodologists, clinicians, regulators, funders, and decision-makers to systematically identify what is known, create a research agenda where gaps exist and translate information into practical guidance for end-users. It is critical that funders, researchers, and editors work together for improved conduct and reporting of trials in the next 5-10 years to ensure that the investment in this area will produce the most reliable and relevant results. The first StaR Child Health summit will take place in Amsterdam on the 26th and 27th of October.
越来越多的证据表明,儿童并非仅仅是小大人,将针对成人医疗护理的证据应用于儿童可能会导致无效甚至不安全的医疗护理。针对儿童的试验数量不断增加,这反映了创建特定于儿童的证据基础的必要性。由于对儿童临床研究的关注度不断提高,以及在应对儿童研究的方法学和实际挑战的最佳方式方面存在明显的知识不足,“儿童健康研究策略(STaR)”倡议应运而生。其目的是加强针对儿童的试验的设计、实施和报告。该倡议汇聚了国际上一批顶尖的方法学家、临床医生、监管人员、资助者和决策者,以系统地梳理已知信息,在存在差距的领域制定研究议程,并将信息转化为针对最终用户的实用指南。至关重要的是,资助者、研究人员和编辑要在未来5至10年共同努力,改进针对儿童的试验的实施和报告,以确保在这一领域的投资能够产生最可靠和相关的结果。首届儿童健康研究策略峰会将于10月26日和27日在阿姆斯特丹举行。